TY  - GEN
AU  - Liu,Chun-Yu
AU  - Hu,Ming-Hung
AU  - Hsu,Chia-Jung
AU  - Huang,Chun-Teng
AU  - Wang,Duen-Shian
AU  - Tsai,Wen-Chun
AU  - Chen,Yi-Ting
AU  - Lee,Chia-Han
AU  - Chu,Pei-Yi
AU  - Hsu,Chia-Chi
AU  - Chen,Ming-Huang
AU  - Shiau,Chung-Wai
AU  - Tseng,Ling-Ming
AU  - Chen,Kuen-Feng
TI  - Lapatinib inhibits CIP2A/PP2A/p-Akt signaling and induces apoptosis in triple negative breast cancer cells
SN  - 1949-2553
PY  - 2016///1230
KW  - Animals
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Apoptosis
KW  - drug effects
KW  - Autoantigens
KW  - Cell Line, Tumor
KW  - Disease Models, Animal
KW  - ErbB Receptors
KW  - antagonists & inhibitors
KW  - Humans
KW  - Lapatinib
KW  - MCF-7 Cells
KW  - Membrane Proteins
KW  - Mice
KW  - Mice, Nude
KW  - Promoter Regions, Genetic
KW  - Protein Kinase Inhibitors
KW  - Protein Phosphatase 2
KW  - Proto-Oncogene Proteins c-akt
KW  - Quinazolines
KW  - Receptor, ErbB-2
KW  - Signal Transduction
KW  - Triple Negative Breast Neoplasms
KW  - drug therapy
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.18632/oncotarget.7035
ER  -